According to research, patients taking efgartigimod, a medication being tested for use in the treatment of chronic primary immune thrombocytopenia (ITP), showed a significantly greater improvement in platelet counts, which are necessary for clotting and stopping bleeding, compared to those t
Patients taking efgartigimod, a drug being studied for use to treat chronic primary immune thrombocytopenia (ITP), exhibited a significantly greater improvement in platelet counts which are essential to clotting and stopping bleeding, compared to those taking a placebo, according to results
Exeter [England], August 1 (ANI): Platelets perform a crucial function in blood, including helping blood to clot, which helps us heal wounds. However, blood platelet counts at the higher end of normal suggest a high risk of cancer in men aged 60 or over and should be investigated, suggests r
Exeter [England], July 28 (ANI): Blood platelet counts at the higher end of normal suggest a high risk of cancer in men aged 60 or over, and should be investigated, according to new University of Exeter research.